The Weekly Litigation News Digest is now live. Subscribe now

Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated Fatigue - EP4349333

The patent EP4349333 was granted to Bhmeke on Oct 30, 2024. The application was originally filed on Jul 28, 2023 under application number EP23188553A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4349333

BHMEKE
Application Number
EP23188553A
Filing Date
Jul 28, 2023
Status
Granted And Under Opposition
Sep 27, 2024
Publication Date
Oct 30, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LANGEJul 29, 2025HERTIN UND PARTNER RECHTS UND PATENTANWALTE PARTG MBBADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0159112
DESCRIPTIONEP3696169
DESCRIPTIONUS2004106651
OPPOSITIONUS2004106651

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents